Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Arrhythmias

Free Subscription Articles published in Br J Pharmacol Retrieve available abstracts of 12 articles: HTML format

Single Articles

April 2024
1. LEI CL, Whittaker DG, Mirams GR
   The impact of uncertainty in hERG binding mechanism on in silico predictions of drug-induced proarrhythmic risk.
   Br J Pharmacol. 2024;181:987-1004.
   PubMed     Abstract available
   
   
   February 2024
2. CHEN IS, Yasuda J, Notomi T, Nakamura TY, et al
   Licorice metabolite 18beta-glycyrrhetinic acid activates G protein-gated inwardly rectifying K(+) channels.
   Br J Pharmacol. 2024;181:447-463.
   PubMed     Abstract available
   
   
   December 2022
3. SAADEH K, Nantha Kumar N, Fazmin IT, Edling CE, et al
   Anti-malarial drugs: Mechanisms underlying their proarrhythmic effects.
   Br J Pharmacol. 2022;179:5237-5258.
   PubMed     Abstract available
   
   
   October 2022
4. CLARK AP, Wei S, Kalola D, Krogh-Madsen T, et al
   An in silico-in vitro pipeline for drug cardiotoxicity screening identifies ionic pro-arrhythmia mechanisms.
   Br J Pharmacol. 2022;179:4829-4843.
   PubMed     Abstract available
   
   
   July 2022
5. KOHAJDA Z, Virag L, Hornyik T, Husti Z, et al
   In vivo and cellular antiarrhythmic and cardiac electrophysiological effects of desethylamiodarone in dog cardiac preparations.
   Br J Pharmacol. 2022;179:3382-3402.
   PubMed     Abstract available
   
   
   June 2022
6. CHAMPEROUX P, Fares R, Bastogne T, Richard S, et al
   Contribution of hemodynamic side effects and associated autonomic reflexes to ventricular arrhythmias triggering by torsadogenic hERG blocking drugs.
   Br J Pharmacol. 2022 Jun 24. doi: 10.1111/bph.15905.
   PubMed     Abstract available
   
   
   
7. BANNISTER ML, MacLeod KT, George CH
   Moving in the right direction: elucidating the mechanisms of interaction between flecainide and the cardiac ryanodine receptor.
   Br J Pharmacol. 2022;179:2558-2563.
   PubMed     Abstract available
   
   
   May 2022
8. HESKETH LM, Sikkel MB, Mahoney-Sanchez L, Mazzacuva F, et al
   OCT2013, an ischaemia-activated antiarrhythmic prodrug, devoid of the systemic side effects of lidocaine.
   Br J Pharmacol. 2022;179:2037-2053.
   PubMed     Abstract available
   
   
   March 2022
9. HORNYIK T, Rieder M, Castiglione A, Major P, et al
   Transgenic rabbit models for cardiac disease research.
   Br J Pharmacol. 2022;179:938-957.
   PubMed     Abstract available
   
   
   
10. LOEN V, Vos MA, van der Heyden MAG
    The canine chronic atrioventricular block model in cardiovascular preclinical drug research.
    Br J Pharmacol. 2022;179:859-881.
    PubMed     Abstract available
    
    
    December 2021
11. ROBINSON VM, Alsalahat I, Freeman S, Antzelevitch C, et al
    A Carvedilol Analogue, VK-II-86, Prevents Hypokalaemia-induced Ventricular Arrhythmia through Novel multi-Channel Effects.
    Br J Pharmacol. 2021 Dec 7. doi: 10.1111/bph.15775.
    PubMed     Abstract available
    
    
    November 2021
12. SANDER P, Feng M, Schweitzer MK, Wilting F, et al
    Approved drugs ezetimibe and disulfiram enhance mitochondrial Ca(2+) uptake and suppress cardiac arrhythmogenesis.
    Br J Pharmacol. 2021;178:4518-4532.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.